tradingkey.logo


tradingkey.logo


LifeMD Inc

LFMD
3.220USD
-0.010-0.31%
取匕時間 ET15分遅れの株䟡
150.00M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 LifeMD Inc 䌁業名

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

LifeMD Incの䌁業情報


䌁業コヌドLFMD
䌚瀟名LifeMD Inc
䞊堎日Jul 11, 2001
最高経営責任者「CEO」Schreiber (Justin)
埓業員数304
蚌刞皮類Ordinary Share
決算期末Jul 11
本瀟所圚地236 Fifth Avenue
郜垂NEW YORK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号10001
電話番号18663515907
りェブサむトhttps://lifemd.com/
䌁業コヌドLFMD
䞊堎日Jul 11, 2001
最高経営責任者「CEO」Schreiber (Justin)

LifeMD Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%
Mr. Dennis Wijnker
Mr. Dennis Wijnker
Chief Technology Officer
Chief Technology Officer
135.00K
+22.73%
Dr. Joan Larovere
Dr. Joan Larovere
Independent Director
Independent Director
107.05K
+26.41%
Mr. Shane Biffar
Mr. Shane Biffar
Chief Compliance Officer and Deputy General Counsel
Chief Compliance Officer and Deputy General Counsel
40.00K
-73.33%
Mr. Calum Macrae, M.D., Ph.D.
Mr. Calum Macrae, M.D., Ph.D.
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Mon, Nov 17
曎新時刻: Mon, Nov 17
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
他の
77.13%
株䞻統蚈
株䞻統蚈
比率
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
他の
77.13%
皮類
株䞻統蚈
比率
Investment Advisor
20.73%
Individual Investor
17.81%
Investment Advisor/Hedge Fund
10.75%
Hedge Fund
7.90%
Research Firm
2.96%
Venture Capital
0.28%
Pension Fund
0.27%
Bank and Trust
0.09%
Insurance Company
0.03%
他の
39.17%

機関投資家保有株


曎新時刻: Sun, Oct 5
曎新時刻: Sun, Oct 5
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
277
24.14M
53.61%
+2.76M
2025Q2
267
25.16M
55.86%
-4.75M
2025Q1
265
25.52M
57.64%
-4.18M
2024Q4
250
23.83M
55.01%
-4.80M
2024Q3
242
24.90M
57.80%
-2.33M
2024Q2
218
23.83M
56.29%
-290.09K
2024Q1
179
22.61M
56.88%
+2.36M
2023Q4
165
20.18M
54.63%
+3.17M
2023Q3
148
17.40M
50.33%
+1.98M
2023Q2
144
16.05M
50.66%
-1.42M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Schreiber (Justin)
2.85M
6.34%
+192.34K
+7.23%
Apr 23, 2025
BlackRock Institutional Trust Company, N.A.
2.41M
5.35%
+107.80K
+4.68%
Jun 30, 2025
The Vanguard Group, Inc.
2.09M
4.63%
+205.62K
+10.93%
Jun 30, 2025
Galluppi (Stefan)
1.79M
3.96%
+30.00K
+1.71%
Aug 22, 2025
Renaissance Technologies LLC
1.09M
2.41%
+600.10K
+123.45%
Jun 30, 2025
Nuveen LLC
1.14M
2.53%
+854.91K
+300.99%
Jun 30, 2025
State Street Investment Management (US)
1.14M
2.53%
+413.24K
+57.01%
Jun 30, 2025
Geode Capital Management, L.L.C.
925.17K
2.05%
+67.44K
+7.86%
Jun 30, 2025
UBS Financial Services, Inc.
937.33K
2.08%
+859.44K
+1103.45%
Jun 30, 2025
Royce Investment Partners
770.45K
1.71%
-384.78K
-33.31%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Kensho New Econ Comp ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Vanguard US Momentum Factor ETF
0.06%
Principal U.S. Small-Cap ETF
0.06%
iShares Micro-Cap ETF
0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Quality Growth Fund
0.02%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
詳现を芋る
State Street SPDR S&P Kensho New Econ Comp ETF
比率0.09%
Vanguard US Multifactor ETF
比率0.08%
Vanguard US Momentum Factor ETF
比率0.06%
Principal U.S. Small-Cap ETF
比率0.06%
iShares Micro-Cap ETF
比率0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
比率0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.03%
WisdomTree US SmallCap Quality Growth Fund
比率0.02%
iShares Russell 2000 Growth ETF
比率0.01%
Global X Russell 2000 ETF
比率0.01%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

LifeMD Incの䞊䜍5名の株䞻は誰ですか


LifeMD Incの䞊䜍5名の株䞻は以䞋のずおりです。
Schreiber (Justin)は2.85M株を保有しおおり、これは党䜓の6.34%に盞圓したす。
BlackRock Institutional Trust Company, N.A.は2.41M株を保有しおおり、これは党䜓の5.35%に盞圓したす。
The Vanguard Group, Inc.は2.09M株を保有しおおり、これは党䜓の4.63%に盞圓したす。
Galluppi (Stefan)は1.79M株を保有しおおり、これは党䜓の3.96%に盞圓したす。
Renaissance Technologies LLCは1.09M株を保有しおおり、これは党䜓の2.41%に盞圓したす。

LifeMD Incの株䞻タむプ䞊䜍3皮は䜕ですか


LifeMD Incの株䞻タむプ䞊䜍3皮は、
Schreiber (Justin)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

LifeMD IncLFMDの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、LifeMD Incの株匏を保有しおいる機関は277瀟あり、保有株匏の総垂堎䟡倀は玄24.14Mで、党䜓の53.61%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-2.25%増加しおいたす。

LifeMD Incの最倧の収益源は䜕ですか


--においお、--郚門がLifeMD Incにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™